The potently hypoxic environment created by the high metabolic demand of a malignant tumor causes cells of the tumor stroma to release chemokines and pro-angiogenic factors that recruit circulating myeloid cells that express pro-angiogenic markers, such as VE-cadherin, CD31, VEGFR2, and TIE2. The gene discussed is TEK; the disease is neoplasm.